Front Row Advisors LLC - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 9 filers reported holding Astellas Pharma Inc in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Front Row Advisors LLC ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q3 2019$10,0000.0%724
-0.4%
0.01%0.0%
Q2 2019$10,000
-37.5%
727
-34.0%
0.01%
-41.7%
Q1 2019$16,000
+14.3%
1,1010.0%0.01%0.0%
Q4 2018$14,0001,1010.01%
Other shareholders
Astellas Pharma Inc shareholders Q3 2023
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 469,618$7,628,0000.31%
TODD ASSET MANAGEMENT LLC 193,500$3,148,0000.07%
SCOUT INVESTMENTS, INC. 225,247$3,665,0000.05%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 193,500$3,148,0000.03%
SILVERCREST ASSET MANAGEMENT GROUP LLC 113,135$1,838,0000.01%
Private Capital Group, LLC 924$15,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 35$1,0000.00%
IFP Advisors, Inc 40$1,0000.00%
First Horizon Advisors, Inc. 120$1,0000.00%
CAPTRUST FINANCIAL ADVISORS 3,790$62,0000.00%
View complete list of Astellas Pharma Inc shareholders